Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Nuvation Bio (NUVB-WT) Goodwill & Intangibles (2024 - 2025)

Nuvation Bio (NUVB-WT) has disclosed Goodwill & Intangibles for 2 consecutive years, with $11.2 million as the latest value for Q4 2025.

  • Quarterly Goodwill & Intangibles rose 142.62% to $11.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $11.2 million through Dec 2025, up 142.62% year-over-year, with the annual reading at $11.2 million for FY2025, 142.62% up from the prior year.
  • Goodwill & Intangibles for Q4 2025 was $11.2 million at Nuvation Bio, down from $11.7 million in the prior quarter.
  • The five-year high for Goodwill & Intangibles was $12.1 million in Q2 2025, with the low at $2.8 million in Q3 2024.